Smith & Nephew reports 3.1% sales growth in Q1 2026, meeting expectations across all business units and regions

seekingalpha.com

Smith & Nephew reported 3.1% underlying sales growth for Q1 2026, meeting expectations with positive performance across all business units and regions. The company saw strong growth in Sports Medicine and resilient results in Advanced Wound Management, despite reimbursement headwinds. U.S. knees were softer as anticipated due to strategic trade-offs. This performance highlights the strength of Smith & Nephew's diversified portfolio, with innovation remaining a key focus for the company.


With a significance score of 0.9, this news ranks in the top 76% of today's 29993 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Smith & Nephew reports 3.1% sales growth in Q1 2026, meeting expectations across all business units and regions | News Minimalist